Fundraising Fox
Zühlke Ventures
Corporate VCZurich · Pre-Seed–Series A · 2 people tracked
Find your way into Zühlke Ventures
1,472 people in our graph share verified history with the Zühlke Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Zühlke Ventures invests exclusively in early-stage HealthTech startups, aiming to recognize potential early, take minority stakes, and support portfolio companies over a 5-8 year horizon. It focuses primarily on Switzerland and Europe, with complementary interests in the US. Beyond capital, it offers access to Zühlke Group's management and technology know-how through a cooperative partnership model. Initial investments range from CHF 150k to 250k per startup.
Source: firm website, verified Aug 3, 2026.
Team · 2 people
from public directories
What they invest in
from 16 of 20 portfolio companiesMedical Devices ×13Healthtech ×11Digital Health ×7Biotech ×3AI & Machine Learning ×2Deep Tech ×2Hardware ×2SaaS ×2
HQs:Switzerland×8United States×5Germany×1Sweden×1
Who they back
founder profiles across 8 portfolio companiesFounding team size:solo founder×42 founders×34+ founders×1
Where their founders worked beforefrom 11 founders with career history
Idiap Research Institute ×2
Investments · 20 tracked
founders shown can be your intro pathBy year:2024 · 12021 · 22020 · 12019 · 15 dated
Tenon Medical develops the Catamaran SI Joint Fusion System, a titanium implant and surgical device that fuses the sacroiliac joint through a less invasive inferior-posterior approach for conditions such as sacroiliac joint disruptions and degenerative sacroiliitis.
HealthtechMedical DevicesLos Gatos, US
Richard Ginn(Chief Technology Officer)inKevin Williamson(Chief Financial Officer)inSteven Foster(Chief Executive Officer and President)inSteven Van Dick(Executive Officer)Wyatt D. Geist(Chief Innovation Officer)inNathaniel A. Grawey(Chief Commercial Officer)
Aluna develops a portable respiratory management tool for children with asthma and other chronic respiratory diseases.
Digital HealthHealthtechMedical Devices
Charvi Shetty(Chief Executive Officer)inInderjit Jutla(Chief Scientific Officer)
Co-investorsBlue Bear VenturesGood Growth CapitalMatrixRho Capital PartnersRho VenturesSOSV
Bottneuro develops MIAMIND, an electrical neurostimulation device for treating early-stage Alzheimer's disease.
BiotechHealthtechMedical Devices
Co-investorsKickfund
Distalmotion develops DEXTER, a surgical robotics system for minimally invasive procedures such as hernia repair, cholecystectomy, and hysterectomy, used by surgeons and clinical teams.
HealthtechMedical DevicesRoboticsLausanne, CH
Co-investors415 Capital4see VenturesPrivilège Ventures
Droplette makes a patented device that converts skincare serums into a fine mist designed to penetrate the skin barrier, sold alongside serum capsules such as its Collagen Boosting Hydrofiller.
ConsumerDirect to ConsumerWellness & FitnessBoston, US
Rathi Srinivas(Executive Officer, Director)inMadhavi Gavini(Executive Officer, Director)
BoardSanto Politi(Director)in
Co-investorsAlumni VenturesBantam GroupVisible VenturesSpark CapitalVictress Capital
DSwiss (operating as SecureSafe) builds Swiss-hosted document security software offering encrypted storage, document exchange, access control, and compliance-ready architecture for organisations handling sensitive financial, legal, and personnel data, as well as individuals.
CybersecurityEnterprise SoftwareSaaSSwitzerland, CH
Andreas(CEO)inGiacomo(CTO)inVeselina(VP Product)inBurkhart(CFO)in
Co-investorsVerium AG
evismo provides diagnostic services using sensor technology to detect cardiac arrhythmias, stress, and sleep apnea for general practitioners and specialists.
Digital HealthHealthtechMedical DevicesZürich, DE
Flow provides a consumer-facing neurostimulation device using transcranial direct current stimulation (tDCS) for depression treatment.
Digital HealthHealthtechMedical DevicesSwitzerland, CH
Flow develops technology-based mental health solutions to address depression symptoms and wellness.
Digital HealthHealthtechMedical DevicesMental HealthStockholm, SE
Daniel Månsson(Co-founder)inErik Rehn(Co-founder)inErin Lee(CEO)in
Co-investorsGlobal BrainJAZZ Venture PartnersKhosla VenturesnaturalX Health VenturesSOSV
Hystrix Medical operates a source-to-contract procurement platform for the healthcare sector, connecting buyers and sellers to manage sourcing, tendering, negotiations, and contract signing (with DocuSign integration) for medical and non-medical spend.
B2B MarketplacesHealthtechSaaS
Co-investorsSICTICStartAngels Network
Indivi is a medical technology company developing tools for precision and personalised medicine in neuroscience research and development, including Bring Your Own Device (BYOD) technology.
AI & Machine LearningDigital HealthHealthtechMedical DevicesBasel, CH
Guilhem Dupont(Chairman, CEO (founder))inCristina Granziera(Co-CEO)Ludwig Kappos(Co-CEO)
Koya Medical develops wearable compression therapy devices, including its Dayspring system, for treating conditions such as lymphedema, chronic venous insufficiency, and deep vein thrombosis.
HardwareHealthtechMedical DevicesOakland, US
Anand Doraiswamy(Executive Officer, Director)in
BoardJosh Baltzell(Director)inJan Garfinkle(Director)in
Co-investorsAphelion CapitalArboretum VenturesScientific Health DevelopmentAsahi Kasei Corporate VenturesCadence Healthcare VenturesOrbiMed
Limula develops an automated, closed platform for manufacturing personalized cell and gene therapies, aiming to move production from open, manual methods to scalable automated processes.
BiotechDeep TechHardwareMedical DevicesLausanne, CH
Thomas Eaton(Founder & CEO)inYann Pierson(Founder & CTO)inCaroline Boudousquié(Head of Solutions)inOlivier Waridel(Head of Operations)in
Co-investorsLifeX VenturesVerve VenturesOxford Seed Fund
.jpeg){kind=logo}
Lunaphore develops spatial biology solutions that enable scientists and clinicians to analyze tissue structure and cellular composition.
BiotechDeep TechMedical DevicesLausanne, CH
Co-investorsOCCIDENTPolytech Ecosystem Ventures
Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes.
Digital HealthMedical DevicesWellness & FitnessPleasanton, US
Shri Raghunathan(Founder)inShriram Raghunathan(Executive Officer, Director)
BoardChau Khuong(Director)inAllan May(Director)Mudit Jain(Director)inTracy Pappas(Director)in
Co-investorsAngelini VenturesBlue Venture FundsOrbiMedTreo Ventures, LlcBridge BankSandbox Clinical Ventures+1 more
PeriVision develops the VisionOne platform, combining AI, virtual reality, and cloud technology to test and understand visual function for eye conditions such as glaucoma.
AI & Machine LearningDigital HealthHealthtechMedical DevicesBasel, CH
Patrick Kessel(Co-founder, CEO & board member)inDr. Serife Kucur(Co-founder & CTO)Serife Kucur Ergunay(Co-founder, CTO & board member)inRaphael Sznitman(Co-founder & board member)inKevin Gillmann(Chief Medical Officer)inBenedetto Sgroi(Chief Commercial Officer)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
KoyaMessage AutomationSwisstom
Exits · 4
1 IPOs · 3 acquisitions · showing 3Tenon MedicalNASDAQ: TNONMessage Automationacq. by BroadridgeSwisstomacq. by Sentec
Portfolio news
latest coverage across their companies
Tenon Medical · biospace.com · Aug 14, 2026
Koya Medical · biospace.com · May 12, 2026
Noctrix Health · finsmes.com · Sep 2, 2025
Frequently asked questions
- How many investments has Zühlke Ventures made?
- Zühlke Ventures has 20 tracked investments, 4 of which have exited.
- What stage does Zühlke Ventures invest at?
- Zühlke Ventures invests at the Pre-Seed, Seed, Series A stages.
- What is Zühlke Ventures's typical check size?
- Zühlke Ventures typically writes checks of $165K – $275K.
- What sectors does Zühlke Ventures focus on?
- Zühlke Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Zühlke Ventures located?
- Zühlke Ventures is headquartered in Zurich, CH.
- Does Zühlke Ventures lead rounds?
- Zühlke Ventures typically participates in rounds rather than leading them.
- Who does Zühlke Ventures co-invest with?
- Zühlke Ventures most often shares deals with SICTIC, StartAngels Network, Arboretum Ventures, among 26 tracked co-investors.
Media · Podcasts & interviews
from their channelAI-assisted software archaeology: turning legacy guesswork into evidence
Zühlke Group
Are leaders deploying AI faster than they can effectively govern it? With Zahra Shah
Zühlke Group
Is it possible for ‘tech for good’ to exist within a for-profit model? With Jim Fruchterman
Zühlke Group
Resilience Rewired: Inside Swissgrid's move to autonomous drone inspection
Zühlke Group
Resilienz neu gedacht: Wie Swissgrid autonome Drohneninspektionen realisiert
Zühlke Group
Is irrational AI making our decision-making worse? With Stephanie Antonian
Zühlke Group
Images
Similar investors
Investinor AS is a Norwegian investment company that partners with founders, entrepreneurs and other investors to help selected promising companies become world-leading.
Arboretum Ventures is a Midwest-based venture capital firm focused on the healthcare industry, investing in early-stage companies across medical devices, life science tools and diagnostics, tech-enabled care delivery, and pharma adjacencies.
Illumina Ventures is a venture investor focused on genomics and precision health, aiming to advance innovation and impact in human health.
Life Sciences Greenhouse Investments (LSGI) is an evergreen venture fund that provides early-stage capital and operational support to Pennsylvania life science companies working on drug discovery, diagnostics, devices, and healthcare IT solutions.
Medical Excellence Capital (MEC) is a venture firm focused on precision health and life sciences, pairing investment professionals and operators with a proprietary national medical network platform.